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ABSTRACT 
Plants belonging to the genus Rumex (family Polygonaceae) are used worldwide in traditional 
medicine for the treatment of various diseases caused by different microorganisms (e.g. 
bacteria-related dermatologic conditions, dysentery and enteritis). The present study focused 
on the antibacterial screening of Rumex species native to the Carpathian Basin, and isolation 
of compounds from one of the most efficient species, Rumex aquaticus. The antibacterial 
effects of n-hexane, chloroform and aqueous fractions of methanol extracts prepared from 
different parts of 14 Rumex species (R. acetosella, R. acetosa, R. alpinus, R. aquaticus, R. 
conglomeratus, R. crispus, R. hydrolapathum, R. obtusifolius subsp. obtusifolius, R. 
obtusifolius subsp. subalpinus, R. patientia, R. pulcher, R. scutatus, R. stenophyllus and R. 
thyrsiflorus) were investigated against Staphylococcus epidermidis, S. aureus, MRSA, 
Bacillus subtilis, Moraxella catarrhalis, Streptococcus pyogenes, S. pneumoniae, S. 
agalactiae, Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae using the 
disc diffusion method. Mainly the n-hexane and chloroform extracts prepared from the roots 
of the plants displayed high antibacterial activity (inhibition zones > 15 mm) against one or 
more bacterial strains. The highly active extracts of the aerial part and root of R. aquaticus 
were subjected to a multistep separation procedure. 19 Compounds, among them naphthalenes 
(musizin, and its glucoside, torachrysone-glucoside, 2-methoxystypandrone), anthraquinones 
(emodin, chrysophanol, physcion, citreorosein, chrysophanol-8-O-glucoside), flavonoids 
(quercetin, quercetin-3,3’-dimethylether, isokaempferide, quercetin 3-O-arabinoside, 
quercetin 3-O-galactoside, catechin), stilbenes (resveratrol, piceid), and 1-stearoylglycerol 
were isolated from the plant. The antibacterial activities of isolated compounds were 
determined, and it was observed that especially naphthalenes exerted remarkable antibacterial 
effects against several bacterial strains. 
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1. Introduction 
Despite the wide spectra of antibacterial pharmaceutics, the hospital-acquired infections 
– also known as nosocomial infections – are still one of the major problems of modern 
medicine. The uncontrolled usage of antibiotics may increase the selection pressure of 
resistant strains. According to the assessment of the World Health Organization, 5-10% of all 
patients in hospitals suffer from nosocomial infection, often caused by methicillin-resistant 
Staphylococcus aureus (MRSA). This bacterium is resistant to penicillin and cephalosporin 
and sensitive only to vancomycin and teicoplanin, however vancomycin-resistant S. aureus 
strains (VRSA) have also been reported [1]. MRSA can cause wound, lower respiratory and 
urinary infections or septicaemia. Severe infections are more common in intensive care units 
and in older population, which can elongate their hospital stays and increase the therapeutic 
costs [2]. Besides MRSA, several bacterial strains, including Staphylococcus epidermidis, 
Moraxella catarrhalis, Streptococcus pyogenes, Pseudomonas aeruginosa, Escherichia coli 
and Klebsiella pneumoniae, can cause nosocomial infections [3–6]. 
The increasing number of resistant strains of microorganisms motivates the 
development of new synthetic and plant-derived antibacterial agents. Plants can be effective 
sources of antimicrobials as they have been traditionally used for centuries to treat different 
microbial infections. More than 70% of pharmacologically active plant derived compounds 
were discovered after ethnomedicinal evaluations of plant species. In case of plant derived 
compounds with antimicrobial activity, large chemical diversity can be observed. This rich 
diversity has partly arisen because of the evolutionary selection for improved defensive 
mechanisms against a broad array of microorganisms [7]. 
Plants belonging to the genus Rumex (family Polygonaceae) are used traditionally for 
the treatment of different diseases related to microbial infections, e.g. dermatologic 
conditions, dysentery, enteritis and ascariasis [8–10]. The antibacterial capacity of several 
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extracts of Rumex species with different polarity have been published in the literature. 
Wegiera et al. tested the inhibitory effects of extracts prepared from R. confertus, R. crispus, 
R. hydrolapathum and R. obtusifolius on the growth of Gram-positive (Staphylococci) and 
Gram-negative (E. coli, P. mirabilis and P. aeruginosa) bacterial strains and different effects 
were detected [11]. The EtOH extract of aerial parts of R. obtusifolius inhibited the growth of 
S. pyogenes [12]. Among the n-hexane, CH2Cl2 and MeOH extracts of the leaves of the same 
plant, the CH2Cl2 extract was active only against E. coli, while the MeOH extract showed 
significant antibacterial effect against all tested bacterial strains (B. cereus, B. subtilis, E. coli, 
ampicillin-resistant E. coli, S. aureus and Salmonella typhii) [13]. 
The MeOH, CHCl3 and ether extracts of different parts of R. vesicarius (collected at 
different vegetative stages) were found to be effective against E. coli, K. pneumoniae, P. 
aeruginosa, S. aureus, S. pneumoniae and and S. pyogenes [14]. Remarkable antibacterial 
activity of the EtOH extract of in vitro germinated seedlings of the same plant was detected 
against P. aeruginosa, E. coli and S. pneumoniae [15]. The MeOH extract of the leaves of R. 
nepalensis had moderate antimicrobial activity against Bacillus cereus, B. subtilis, E. coli and 
P. aeruginosa [16]. In another investigation, antibacterial activities of different parts of the 
plant were also determined. The highest inhibition was recorded in case of leavesH2O extract 
against E. coli [17]. The benzene and EtOAc extracts prepared from the roots of the same 
plant showed significant activity against S. aureus, S. mutans, E. coli and P. aeruginosa [18].  
Evaluation of the antibacterial activity of various extracts gained from aerial parts of R. 
japonicus revealed that the EtOAc extract possessed the strongest antibacterial activity against 
B. subtilis, B. cereus and E. coli. It was correlated with the high amount of phenolic 
compounds presented in the extract [19]. 70% MeOH extract of R. dentatus showed 
antibacterial activity against B. megaterium, B. subtilis, Enterobacter cloacea and P. 
aeruginosa [20]. R. nervosus and R. abyssinicus exhibited activity against S. pyogenes and 
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Corynebacterium diphtheriae. Neither of the plants were active against the Gram negative P. 
aeruginosa and E. coli [21]. The EtOAc extract of R. hastatus was highly active against S. 
aureus and E.coli [22]. The EtOH and MeOH extracts of the leaves of R. alveolatus exhibited 
dose-dependent antibacterial activity against S. aureus and P. aeruginosa [23]. The EtOH 
extracts of leaves of R. chalepensis showed high activity against multi-resistant E. coli, S. 
aureus and P. aeruginosa [24]. 
R. patientia subsp. pamiricus, which is used to treat inflammatory ailments, pain, fever 
and infections in the Pamir Mountains in North-East Afghanistan, had weak inhibitory effect 
against S. aureus, E. coli, B. subtilis and P. aeruginosa [25]. The aerial parts of R. alpinus and 
R. caucasicus, extracted with H2O and MeOH, were screened for antibacterial activity against 
52 bacterial strains. It was concluded that methanol is a better solvent for extracting 
antimicrobial substances compared to water. The plant extracts did not show any selectivity 
against Gram-negative or Gram-positive bacteria [26]. 
This study aimed to screen the antibacterial activity of Rumex species, collected in the 
Carpathian Basin, against standard bacterial strains. The further objective of this work was the 
isolation of the pharmacologically active components of the most active species, R. aquaticus. 
From the investigated species (n = 14), only R. crispus and R. hydrolapathum were tested 
previously for antibacterial activity [11]. 
 
2. Experimental 
 
2.1. General procedures 
 
NMR spectra were recorded in DMSO (dimethyl sulfoxide), on a Bruker Avance DRX 
500 spectrometer at 500 MHz (
1
H) or 125 MHz (
13
C); the signals of the deuterated solvent 
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were taken as reference. Two-dimensional (2D) experiments (
1
H–1H COSY, HSQC, HMBC 
and NOESY) were set up, performed and processed with the standard Bruker protocol. 
ESIMS was performed on an API 2000 instrument in APCI positive mode. Separations with 
medium pressure liquid chromatography (MPLC) was carried out on a Büchi MPLC (Pump 
Manager C615, Pump Module C605) using silica gel (Kieselgel 60, 40-63 μm, Merck, 
1.09385.1000) or prepacked RP-cartridge (RP18ec sorbent, 40-63 μm, Büchi, 054863). HPLC 
was carried out on a Wufeng LC-100 HPLC, using normal (LiChrospher Si60 (5 μm) 
LiChroCART 125-4) and reverse phase [Phenomenex, Kinetex 5u C18 100A; LiChrospher 
LiChroCART 250-4 RP-18e (5 μm)] columns. For vacuum liquid chromatography (VLC), 
silica gel (60G, 15 µm, Merck 11677) was applied. Silica gel plates were applied for 
analytical and preparative TLC (Merck 5717 and 5715). Polyamide (MP Biomedicals) and 
Sephadex LH-20 were used for column chromatography (CC and GFC). Reverse phase 
column chromatography was carried out on reverse phase silica gel (LiChroprep RP-18, 40-63 
μm, Merck). Separation was monitored at UV 254 nm. 
 
2.2. Plant material 
 
Plants were collected mainly in the flowering period between June and September 
2010 (R. aquaticus was collected in July 2013), in several regions of the Carpathian Basin 
(Hungary and Romania). Botanical identification of the plant material was performed by Dr. 
Gusztáv Jakab (Institute of Environmental Sciences, Szent István University, Szarvas, 
Hungary) and voucher specimens (No. 790-803 and 816) have been deposited at the 
Department of Pharmacognosy, University of Szeged, Szeged, Hungary. 
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2.3. Extraction of plant samples 
 
For the antimicrobial-screening assay, extracts were prepared from 10 g of air-dried 
plant materials [root, herb (aerial parts of small-stature plants with small leaves or flowers), 
leaves or flowers] with 3 × 100 mL of MeOH, then the solutions were evaporated to dryness 
under vacuum. The residues were dissolved in 50 mL of 50% aqueous MeOH and then 
solvent–solvent partitions were performed between n-hexane (3 × 50 mL) (extracts A) and 
chloroform (3 × 50 mL) (extracts B), and the residues gave extracts C. The yields (w/w) of 
the extracts are shown in Table 1. 
 
2.4. Isolation of compounds from R.aquaticus 
 
2.4.1. Isolation of compounds from the aerial parts of R. aquaticus 
 
The dried aerial part of R. aquaticus (550 g) was percolated with MeOH (15 L) at room 
temperature. The crude extract was concentrated to 200 mL under reduced pressure, the 
residue was dissolved in 200 mL 50% aqueous MeOH and solvent–solvent partition was 
performed with n-hexane (3 × 500 mL) and CHCl3 (3 × 500 mL). In order to remove water 
soluble compounds, the remaining aqueous fraction was partitioned with EtOAc (3 × 500 
mL). The CHCl3 fraction (5 g) was separated first on polyamide CC, using the gradient 
system of MeOH–H2O (1:4, 2:3, 3:2 and 4:1). The fraction eluted with 40% MeOH was 
separated by RP-VLC (MeOH–H2O from 3:7 to 7:3) to yield five subfractions. The separation 
of subfraction 4 by VLC (CH2Cl2–MeOH from 99:1 to 8:2) resulted in five fractions. From 
fraction 4, compound 3 (10 mg) was isolated by preparative TLC (MeOH–H2O 6:4). From 
fraction 5, compound 10 (7.6 mg) was crystallized. The fraction eluted with 80% MeOH from 
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polyamide column was further separated by RP-VLC (MeOH–H2O from 1:1 to 9:1) to afford 
15 subfractions. From subfraction 4, compounds 14 (2.5 mg) and 15 (1.5 mg) were isolated by 
preparative TLC, using CH2Cl2–MeOH 9:1 as eluent. Further separation of subfraction 14 by 
VLC (n-hexane–EtOAc–MeOH from 8:2:0 to 5:5:1) resulted compound 19 (55 mg). 
After evaporation, the EtOAc fraction (30 g) was separated by VLC on silica gel (60 
GF254 15 μm) with gradient mixtures of CHCl3–MeOH (from 99:1 to 1:1). Fractions with 
similar composition were combined to afford fractions F1–F16. From F5, compound 8 (3.4 
mg) was isolated by gel filtration chromatography (GFC), using using CH2Cl2–MeOH (1:1) 
as eluent. 
After GFC fractionation of F7, nine subfractions were obtained. Separation of 
subfraction 6 by RP-VLC (using gradient mixtures of MeOH–H2O from 1:1 to 8:2) resulted in 
four fractions. From fractions 2 and 3, compound 11 (8.1 mg) was isolated by RP-HPLC 
(MeOH–H2O 3:2, with the flow rate of 1 mL/min, tR = 3.3 min). 
Fractionation of F8 by GFC afforded eight subfractions. From subfraction 6, compound 
13 (4.5 mg) was isolated using RP-HPLC (MeOH–H2O 3:2, with a flow rate of 1 ml/min, tR = 
6 min). Fractionation of F9 by reverse phase medium pressure liquid chromatography (RP-
MPLC), using gradient system of MeOH–H2O, resulted in nine subfractions. Further 
separation of subfraction 1 by GFC, yielded four fractions. Compound 18 (6.3 mg) was 
isolated from fraction 3 by preparative RP-TLC (MeOH–H2O 7:3). From subfraction 4, 
compound 16 (150.6 mg) was crystallized. Further fractionation of subfraction 6, using GFC, 
six fractions were obtained. From fraction 2, compound 2 (5.3 mg) was isolated by 
preparative TLC (EtOAc–MeOH–H2O 100:16:12), while compound 9 (6.4 mg) was 
crystallized from fraction 6. Finally, compound 17 (139.7 mg) was crystallized from F11. 
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2.4.2. Isolation of compounds from the roots of R. aquaticus 
 
The dried roots (800 g) were percolated with MeOH (35 L) at room temperature. The 
crude extract was concentrated to 400 mL under reduced pressure, the residue was dissolved 
in 200 mL 50% aqueous MeOH and solvent–solvent partition was performed with n-hexane 
(3 × 500 mL), CHCl3 (3 × 500 mL) and EtOAc (3 × 500 mL). After evaporation, the n-hexane 
fraction (14 g) was separated by VLC on silica gel (60 GF254, 15 μm) with gradient mixtures 
of CHCl3–MeOH (from 99:1 to 1:9), to afford fractions 1-14. From fraction 2, compound 6 
(15.6 mg) was crystallized. Further separation of fraction 3 by VLC, using cyclohexane–
EtOAc gradient systems (from 99:1 to 6:4), six subfractions were obtained. From subfraction 
3, compound 1 (14.2 mg) was isolated by preparative TLC (cyclohexane–EtOAc 8:2). 
Separation of fraction 5 with RP-VLC (MeOH–H2O gradient, from 6:4 to 99:1) resulted 
in eight subfractions. From subfraction 2, compound 4 (10.2 mg) was isolated by preparative 
TLC (cyclohexane–EtOAc–MeOH 7:3:1). 
After evaporation, the CHCl3 fraction (7 g) was subjected to MPLC on silica gel with 
gradient mixtures of CHCl3–MeOH (from 99:1 to 6:4), to afford eleven subfractions. From 
subfraction 8, compound 10 (4.4 mg) was obtained by RP-VLC (MeOH–H2O from 1:1 to 
99:1). 
After evaporation, the EtOAc fraction (100 g) was separated by CC on polyamide, using 
the gradient system of MeOH–H2O (2:3, 1:1, 3:2 and 4:1). Further separation of the fraction 
eluted with MeOH–H2O 2:3 by VLC (CH2Cl2–MeOH from 95:5 to 8:2) resulted in nine 
subfractions. From subfraction 8, compound 12 (20.7 mg) was isolated using preparative TLC 
(CH2Cl2–MeOH 8:2). Separation of the fraction eluted with MeOH–H2O 1:1 by VLC 
(CH2Cl2–MeOH from 99:1 to 8:2) nine subfractions were obtained. From subfraction 1 
compound 6 (6.5 mg) and 7 (4.4 mg) were isolated by HPLC (cyclohexane–EtOAc 95:5, flow 
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rate = 1.5 mL/min, tR = 4.46 and 6.36 min). From subfraction 3, compound 5 (5.2 mg) was 
isolated by RP-HPLC (MeOH–H2O 8:2, flow rate = 1 mL/min, tR = 3.6 min). Finally, from 
subfraction 4, compounds 2 (7.5 mg) and 3 (10.3 mg) were yielded by RP-HPLC (MeOH–
H2O 1:1, flow rate = 1 mL/ml, tR = 1.6 and 2.6 min). 
 
2.5. Antimicrobial assay 
 
Antimicrobial activity of the plant extracts was tested against 11 bacterial strains 
(Staphylococcus aureus ATCC 29213, methicillin-resistant Staphylococcus aureus ATCC 
43300, Staphylococcus epidermidis ATCC 1228, Bacillus subtilis ATCC 6633, Moraxella 
catarrhalis ATCC 43617, Streptococcus pyogenes ATCC 19615, Streptococcus pneumoniae 
ATCC 49619, Streptococcus agalactiae ATCC 13813, Pseudomonas aeruginosa ATCC 
27853, Escherichia coli ATCC 35218 and Klebsiella pneumoniae ATCC 700603). The 
antibacterial screening assay was performed by disc-diffusion method. The test organisms (S. 
aureus, methicillin-resistant S. aureus, S. epidermidis, B. subtilis, P. aeruginosa, E. coli and 
K. pneumoniae) were cultured at Mueller-Hinton agar plates (bio-Mérieux) at 37 °C. 
Columbia agar + 5% sheep blood (COS) plates (bio-Mérieux) were used for growing of M. 
catarrhalis, S. pyogenes, S. pneumoniae, and S. agalactiae. The bacteria isolates were picked 
from overnight cultures and suspensions were prepared in sterile saline solution by adjusting 
the turbidity to match 0.5 McFarland standards to give a resultant concentration of 1-2 × 10
8
 
cfu/mL. The sterile filter paper discs (6 mm diameter) impregnated with the extracts (10 μL of 
dried extracts redissolved in DMSO at 50 mg/mL) or the isolated compounds (10 μL, 
dissolved in DMSO at 10 mg/mL) were placed on the agar plate seeded with the respective 
bacteria. The solvent (DMSO) was served as negative control. The plates were then incubated 
at 37 °C for 24 h under aerobic conditions. The entire diameters of inhibition zone (including 
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the disc) produced by the plant extracts was measured and recorded. It was observed that 
DMSO did not inhibit the growth of microorganisms in this used concentration. Erythromycin 
and vancomycin served as positive controls at 15 μg/disc. 
The active extracts and compounds (purity > 96%) were further subjected to determine 
their minimal inhibitory concentration (MICs) by microdilution method. Briefly, in the 96-
well plates the stock solutions of extracts (50 mg/mL in DMSO) were serially diluted with 
Mueller-Hinton broth to arrive at final concentration between 2.5 mg/mL and 4.9 µg/mL. 100 
µL of inoculum (0.5 McFarland, 1-2 × 10
8
 CFU/mL) were then added to the wells. A sterility 
check (medium and DMSO in amount corresponding to the highest concentration), negative 
control (medium, DMSO and inoculum) and positive control (medium, DMSO, inoculum and 
vancomycin) were included for each experiment. The plates were then incubated at 37 °C for 
24 hours under aerobic environment. The MIC of preparation was the lowest concentration 
that completely inhibited the visible bacterial growth. 
 
3. Results and discussion 
 
In the course of our screening study, the antibacterial activities of 14 species of the 
Rumex genus (R. acetosella L., R. acetosa L., R. alpinus L., R. aquaticus L., R. conglomeratus 
Murr., R. crispus L., R. hydrolapathum Huds., R. obtusifolius subsp. obtusifolius L., R. 
obtusifolius subsp. subalpinus (Schur) Čelak., R. patientia L., R. pulcher L., R. scutatus L., R. 
stenophyllus Ledeb. and R. thyrsiflorus Fingerh.) occurring in the Carpathian Basin were 
evaluated. The results of the assays are listed in Table 1. The extracts were prepared with 
methanol from selected plant organs and then solvent–solvent partitions were made with n-
hexane (A) and CHCl3 (B). The remaining aqueous fractions were signed as (C) (altogether 
84 extracts). According to the size of the inhibition zone (mm), antibacterial effects causing 
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<10 mm inhibition were considered weak, 10-15 mm inhibition were considered moderate, 
while15< mm were considered strongly active. At 50 mg/mL (500 µg/disc), a total of 42 
extracts demonstrated antimicrobial activity against at least one of the tested microbial strains. 
Among the fractions with different polarities, fractions B (containing CHCl3-soluble 
lipophilic constituents) and fractions C (remaining aqueous fractions) proved to be active. The 
n-hexane extracts (fractions A) showed pronounced antimicrobial effects in only a few cases 
(R. alpinus roots, R. aquaticus roots and R. patientia roots). 
From the active fractions, three n-hexane extracts [R. alpinus roots (A) (26.5 ± 1.5 
mm), R. aquaticus roots (A) (18.7 ± 0.6 mm) and R. patientia roots (A) (21.4 ± 1.2 mm) 
against S. aureus and R. alpinus roots (A) on MRSA (16.8 ± 1.2 mm)]; four CHCl3-soluble 
fractions [R. acetosa roots (B) on S. epidermidis (18.5 ± 1.5 mm) and S. aureus (16.0 ± 1.0 
mm); R. conglomeratus herbs (B) on M. catarrhalis (18.4 ± 0.8 mm); R. crispus roots (B) 
against S. pneumoniae (16.6 ± 0.6 mm); R. pulcher whole plant (B) on B. subtilis (16.5 ± 0.6 
mm)] and two aqueous extracts [R. crispus herb (C) (15.5 ± 0.5 mm) and R. patientia flowers 
(C) (16.3 ± 0.2 mm) against S. epidermidis] exerted strong antibacterial activity against at 
least one bacterial strains. 
Concerning the bacterial strains, P. aeruginosa, E. coli, K. pneumoniae, S. pyogenes 
and S. agalactiae showed resistance against most of the extracts and only the chloroform 
fractions prepared from the roots of R. acetosa, R. alpinus, R. aquaticus and R. crispus proved 
to be active against the last two strains listed above. The n-hexane extract (A) of R. alpinus 
roots had high inhibitory activity against MRSA, while 28 of the total extracts showed weak 
or moderate activity against this bacterium. 
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Table 1. 
Antibacterial activity of Rumex species on different bacterial strains 
Species 
Plant 
parts 
Fraction 
Yield  
(w/w%) 
Antibacterial activity (inhibition zone in mm) 
S. 
epidermidis 
S. aureus MRSA B. subtilis M. 
catarrhalis 
S. 
pyogenes 
S. 
pneumoniae 
S. 
agalactiae 
Rumex acetosella L. whole 
plant 
A 2.9 - - - - - - - - 
B 2.9 - - - - - - - - 
 C 3.9 - - - - - - - - 
R. acetosa L. 
 
herbs A 5.0 - - - - - - - - 
 B 3.4 - - - - - - 7.5 ± 0.5 - 
 C 8.2 - - - - - - - - 
roots A 1.8 - - - - - - 7.0 ± 0 - 
 B 3.3 18.5 ±1.5 16.0 ± 1 12.4 ± 0.6 12.2 ± 0.8 10.2 ± 0.4 8.0 ± 0 8.5 ± 1 - 
 C 13.6 9.0 ± 0 8.0 ± 0 9.0 ± 0 - 7.5 ± 0.5 - - - 
R. alpinus L. flowers/  A 1.9 - - - - - - - - 
fruits B 2.4 - 11.5 ± 0.5 - - 7.4 ± 0.6 - - - 
 C 12.6 8.0 ± 1.0 8.4 ± 0.4 8.0 ± 0 7.5 ± 1.5 7.0 ± 0 - - - 
leaves A 3.7 - - - - - - - - 
 B 2.2 - - - - - - - - 
 C 13.4 - - - - - - - - 
roots A 2.4 14.4 ± 1.2 26.5 ± 1.5 16.8 ± 1.2 12.0 ± 1.0 10.3 ± 0.6 - 10.6 ± 0.6 - 
 B 3.9 12.2 ± 0.6 8.0 ± 0 - 7.5 ± 0.5 - - 8.0 ± 0 10.4 ± 0.8 
 C 21.7 8.0 ± 0 7.4 ± 0.6 7.4 ± 0.6 - - - - - 
R. aquaticus L. herbs A 3.3 - - - - - - - - 
 B 1.4 - - - - - - - - 
 C 6.3 10.0 ± 0 10.3 ± 0.6 11.3 ± 0.6 9.6 ± 0.6 12.7 ± 0.6 - - - 
roots A 1.4 12.3 ± 0.6 18.7 ± 0.6 9.0 ± 0 10.3 ± 1.5 12.0 ± 0.5 - 10.5 ± 0.5 - 
 B 2.1 13.3 ± 1.5 9.0 ± 0.5 - 9.7 ± 0.6 8.0 ± 0 11.3 ± 0.6 11.0 ± 1.0 - 
 C 18.4 12.0 ± 0 13.0 ± 1.0 10.7 ± 0.6 10.3 ± 0.6 12.7 ± 0.6 - - - 
R. conglomeratus Murr. herbs A 3.3 - - - - - - - - 
 B 6.3 11.4 ± 0.6 8.4 ± 0.4 8.0 ± 0 8.5 ± 0.5 18.4 ± 0.8 - 10.5 ± 0.5 - 
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Species 
Plant 
parts 
Fraction 
Yield  
(w/w%) 
Antibacterial activity (inhibition zone in mm) 
S. 
epidermidis 
S. aureus MRSA B. subtilis M. 
catarrhalis 
S. 
pyogenes 
S. 
pneumoniae 
S. 
agalactiae 
 C 10.6 10.0 ± 1.0 10.8 ± 0.6 9.2 ± 0.4 9.5 ± 1.0 7.0 ± 0 - - - 
R. crispus L.  herbs A 2.0 - - - - - - - - 
 B 3.1 - - - - - - - - 
 C 7.8 15.5 ± 0.5 12.4 ± 0.6 12.0 ± 0.5 10.2 ± 0.6 10.6 ± 0.6 - - - 
leaves A 3.3 - - - - - - - - 
 B 2.7 - - - - - - - - 
 C 5.6 - - - - - - - - 
roots A 2.4 - - - - - - - - 
 B 4.4 - - - - - 12.4 ± 0.8 16.6 ± 0.6 - 
 C 16.6 8.0± 0.5 8.5 ± 1.0 8.5 ± 0.5 - - - - - 
R. hydrolapathum Huds. leaves A 2.1 - - - - - - - - 
 B 2.9 - - - - - - - - 
 C 14.5 10.5 ± 0.5 10.4 ± 0.8 8.0 ± 0 10.8 ± 0.6 8.5 ± 1.0 - - - 
roots A 1.0 - - - - - - - - 
 B 4.5 - - - - - - - - 
 C 25.0 12.4 ± 0.8 12.5 ± 0.5 12.3 ± 0.6 13.1 ± 0.4 12.4 ± 0.7 - - - 
R. obtusifolius subsp. 
obtusifolius L. 
herbs A 7.5 - - - - - - - - 
 B 3.8 - - - - - - - - 
 C 7.1 8.4 ± 0.6 8.0 ± 0.5 8.5 ± 1.5 - - - - - 
roots A 3.0 - - - - - - - - 
 B 3.3 - - - - - - - - 
 C 14.3 12.1 ± 0.4 11.4 ± 0.8 10.0 ± 0.5 12.6 ± 0.6 10.5 ± 1.5 - - - 
R. obtusifolius subsp. 
subalpinus (Schur) 
Čelak. 
herbs  A 3.8 - - - - - - - - 
 B 1.2 8.4 ± 0.4 9.5 ± 1.0 - - - - 8.0 ± 0 - 
 C 6.2 12.5 ± 0.5 10.3 ± 0.6 10.8 ± 0.8 12.6 ± 1.2 7.0 ± 0.5 - - - 
roots A 0.9 - - - - - - 7.5 ± 1.5 - 
 B 1.4 12.8 ± 1.4 7.5 ± 0.5 10.4 ± 0.8 - - - 7.4 ± 0.4 - 
 C 31.7 - - 7.3 ± 0.6 - - - - - 
R. patientia L. flowers A 3.9 - - - - - - - - 
 B 4.0 - - - - - - - - 
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Species 
Plant 
parts 
Fraction 
Yield  
(w/w%) 
Antibacterial activity (inhibition zone in mm) 
S. 
epidermidis 
S. aureus MRSA B. subtilis M. 
catarrhalis 
S. 
pyogenes 
S. 
pneumoniae 
S. 
agalactiae 
 C 6.0 16.3 ± 0.2 13.7 ± 0.4 12.6 ± 0.3 10.8 ± 0.7 12.5 ± 0.5 - - - 
leaves A 3.5 - - - - - - - - 
 B 0.7 - - - - - - - - 
 C 3.6 - - - - - - - - 
roots A 2.4 13.3 ± 0.6 21.4 ± 1.2 8.4 ± 0.4 14.6 ± 1.2 11.6 ± 0.8 - 14.5 ± 1.0 - 
 B 3.0 10.0 ± 0.5 10.0 ± 0.5 10.6 ± 0.6 8.3 ± 0.6 10.0 ± 1.0 10.4 ± 0.6 12.8 ± 0.6 - 
 C 22.4 8.5 ± 1.0 8.0 ± 0 8.4 ± 0.4 - - - - - 
R. pulcher L. whole  A 3.5 - - - - - - - - 
plant B 1.6 - - - 16.5 ± 0.6  - - - - 
 C 8.8 9.2 ± 0.4 - 8.8 ± 0.4 - 7.2 ± 0.3 - - - 
R. scutatus L. whole  A 4.7 - - - - - - - - 
plant B 3.4 - - - 10.4 ± 0.3 - - - - 
 C 7.0 - - - - - - - - 
R. stenophyllus Ledeb. flowers/  A 3.7 - - - - - - - - 
fruits B 5.5 - - - - - - - - 
 C 12.6 14.3 ± 0.7 12.2 ± 0.6 11.0 ± 0.5 10.6 ± 0.7 10.3 ± 0.4 - - - 
leaves A 2.0 - - - - - - - - 
 B 0.6 - - - - 7.0 ± 0.5 - - - 
 C 8.8 - - - - - - - - 
roots A 2.4 - 10.5 ± 0.5 - - - - - - 
 B 5.4 10.4 ± 0.7 12.7 ± 0.3 - - - - 10.5 ± 0.5 - 
 C 17.3 12.1 ± 0.8 9.0 ± 1.5 10.6 ± 0.8 - 8.7 ± 0.6 - - - 
R. thyrsiflorus Fingerh. herbs A 3.6 - - - - - - - - 
 B 2.6 - 7.5 ± 0.5 - - 7.3 ± 0.7 - 7.3 ± 0.6 - 
 C 7.1 - 7.8 ± 0.6 8.7 ± 0.3 - 7.6 ± 0.6 - - - 
roots A 1.3 - - - - - - - - 
 B 2.2 - - - - - - - - 
 C 6.3 11.3 ± 0.6 12.3 ± 0.6 9.7 ± 0.6 10.3 ± 0.6 10.7 ± 1.2 - - - 
Erythromycin (15    32.1 ± 0.7 27.0 ± 0.5 - 30.4 ± 0.2 32.2 ± 0.8 24.4 ± 0.6 32.1 ± 0.3 30±0.4 
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Species 
Plant 
parts 
Fraction 
Yield  
(w/w%) 
Antibacterial activity (inhibition zone in mm) 
S. 
epidermidis 
S. aureus MRSA B. subtilis M. 
catarrhalis 
S. 
pyogenes 
S. 
pneumoniae 
S. 
agalactiae 
µg/disc) 
vancomycin (5 µg/disc) - - 15.5 ± 0.6 - - - - 17±0.2 
A: n-hexane fraction, B: chloroform fraction, C: remaining aqueous fraction, -: diameter of inhibition zone ˂5 mm 
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Regarding the different plant parts of Rumex species, usually the roots proved to have 
significant effects against multiple bacterial strains. For example, in case of R. patientia, the 
leaf extract did not possess any antibacterial activity; in case of its flowers only the extract C 
was active, while the root extract of the plant showed activity against almost all bacterial 
strains. 
The aqueous fraction (C) of the aerial parts of R. aquaticus, and the n-hexane (A), 
chloroform (B) and aqueous (C) fractions of the roots of R. aquaticus possessed remarkable 
antimicrobial effects (Table 1). With the combination of different chromatographic methods 
(RP-VLC, prepTLC and HPLC), 19 compounds were isolated from R. aquaticus. The 
structure determination of the compounds was performed by 1D and 2D NMR, and HRMS 
investigations and with comparison of their spectral data with those reported in the literature. 
The identified compounds were the naphtalenes musizin (1) [27], musizin-8-O-glucoside (2) 
[28], and torachrysone-glucoside (3) [29]; the naphtoquinone 2-methoxystypandrone (4) [30]; 
the anthraquinones emodin (5), chrysophanol (6), physcion (7) [31], citreorosein (8) [32], 
emodin-8-O-glucoside (9) [33], and chrysophanol-8-O-glucoside (10) [34]; the stilbenes 
resveratrol (11) [35] and piceid (12) [36]; and the flavonoids quercetin (13), quercetin-3,3’-
dimethylether (14) [37], isokaempferide (15) [38], quercetin 3-O-arabinoside (16), quercetin 
3-O-galactoside (17), and catechin (18) [39]; and the monoacylglycerol 1-stearoylglycerol 
(19) [40]. Apart from musizin-8-O-glucoside, all compounds were isolated for the first time 
from R. aquaticus. 
Among the isolated compounds musizin (MIC = 57.8 μM, in case of M. catarrhalis; 
MIC = 231.5 μM, in cases of S. epidermidis, S. aureus and B. subtilis; and MIC = 463 μM, in 
case of MRSA), and its glycoside (musizin-8-O-glucoside, MIC = 529.1 μM, in case of B. 
subtilis), and 2-methoxystypandrone (MIC = 48 μM, in case of M. catarrhalis; MIC = 96 μM, 
in cases of S. aureus and B. subtilis; and MIC = 192.3 μM, in cases of S. epidermidis and 
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MRSA) showed remarkable antibacterial activity, while other compounds proved to be 
inactive. The aglycon musizin was more active, than its glucoside. 
Previously naphthalenes were also isolated from other Rumex species (R. alpinus, R. 
crispus, R. dentatus, R. hastatus, R. japonicus, R. nepalensis and R. patientia) [10]. The 
antimicrobial effect of 2-methoxystypandrone, musizin and torachrysone was tested and 2-
methoxystypandrone proved to be active against S. aureus, S. lutea and S. cerevisiae [41]. 
In conclusion, the results of our screening study serve as a good starting point for 
selection of Rumex species and their different extracts with antibacterial properties for future 
work. These species, especially R. acetosa, R. alpinus, R. aquaticus, R. conglomeratus and R. 
patientia, are promising candidates for further activity-guided fractionation to find new 
antibacterial natural compounds. Phytochemical and pharmacological investigation of R. 
aquaticus resulted in the isolation of 19 compounds, among them naphthalenes (musizin, 
musizin-8-O-glucoside and 2-methoxystipandron) can be at least partly responsible for the 
antibacterial activity of the plant. 
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